AbbVie bolsters presence in Ireland with €60m investment
The company will deploy capital to build a new facility and to introduce upgrades across the Cork site to improve its overall carbon footprint.
The company will deploy capital to build a new facility and to introduce upgrades across the Cork site to improve its overall carbon footprint.
GSK pays for the exclusive license of Spero‘s late-stage antibiotic to potentially treat complicated urinary tract infections.
The two companies have agreed an exclusive collaboration that will see Aptar’s SmartTrack testing service be complemented by Fluidda’s functional respiratory imaging technology.